Study on the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients

被引：0
|
作者：
Chen, Fei [1 ]
Li, Hongbo [2 ]
Zhang, Huanming [1 ]
机构：
[1] Jinhu Cty Peoples Hosp, Dept Oncol, 160 Shenhua Ave, Huaian, Jiangsu, Peoples R China
[2] Jinhu Cty Peoples Hosp, Dept Rehabil, Huaian, Peoples R China
来源：
MINERVA GASTROENTEROLOGY | 2024年 / 70卷 / 01期
关键词：
D O I：
10.23736/S2724-5985.23.03490-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：135 / 137
页数：3
相关论文
共 50 条
  • [41] Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis
    Kobayashi, Nobuaki
    Katakura, Seigo
    Kamimaki, Chisato
    Somekawa, Kohei
    Fukuda, Nobuhiko
    Tanaka, Katsushi
    Watanabe, Keisuke
    Horita, Nobuyuki
    Hara, Yu
    Piao, Hongmei
    Kaneko, Takeshi
    THORACIC CANCER, 2021, 12 (07) : 1096 - 1105
  • [42] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer
    Lin, Chia-Chi
    Yang, Chih-Hsin
    TARGETED ONCOLOGY, 2009, 4 (01) : 37 - 44
  • [43] Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Keam, Bhumsuk
    Kim, Dong-Wan
    Park, Jin Hyun
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Chung, Doo Hyun
    Heo, Dae Seog
    CANCER RESEARCH AND TREATMENT, 2014, 46 (04): : 323 - 330
  • [44] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer
    Chia-Chi Lin
    Chih-Hsin Yang
    Targeted Oncology, 2009, 4 : 37 - 44
  • [45] Antitumoral Activity of Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harbouring Rare Epidermal Growth Factor Receptor Mutations
    Oyaert, Matthijs
    Demedts, Ingel
    Boone, Elke
    Dedeurwaerdere, Franceska
    Vandorpe, Jo
    De Laere, Emmanuel
    Breyne, Joke
    MOLECULAR DIAGNOSIS & THERAPY, 2015, 19 (05) : 267 - 272
  • [46] Second-generation epidermal growth factor tyrosine kinase inhibitors in non-small cell lung cancer
    Mukherji, Deborah
    Spicer, James
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (03) : 293 - 301
  • [47] The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
    Belloni, Alessia
    Pugnaloni, Armanda
    Rippo, Maria Rita
    Di Valerio, Silvia
    Giordani, Chiara
    Procopio, Antonio Domenico
    Bronte, Giuseppe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 194
  • [48] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
    Liao, Bin-Chi
    Lee, Jih-Hsiang
    Lin, Chia-Chi
    Chen, Ya-Fang
    Chang, Chin-Hao
    Ho, Chao-Chi
    Shih, Jin-Yuan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1754 - 1761
  • [49] Treatment For Patients With Non-Small Cell Lung Cancer With Acquired Resistance To Epidermal Growth Factor-Tyrosine Kinase Inhibitors
    Watanabe, S.
    Takeda, Y.
    Hirano, S.
    Katsuya, Y.
    Ishii, S.
    Naka, G.
    Sugiyama, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [50] Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer
    Noda, Shoko
    Kanda, Shintaro
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (05) : 547 - 556
12345